Back to Stock Dashboard
Sector:
Healthcare
Add to portfolio
SOLV
Solventum Corporation
Solventum Corporation (SOLV) is rated C+ (2.6/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Momentum (B); its weakest is Growth (C-).
Quantitative Factor Evaluation • Updated
Overall Rating
2.6
/ 5.0
C+
Value
C-
Factor Score
2.1
/ 5.0
Growth
C-
Factor Score
1.9
/ 5.0
Profitability
B
Factor Score
3.4
/ 5.0
Momentum
B
Factor Score
3.4
/ 5.0
Revisions
C
Factor Score
2.4
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
100.1
EV / EBITDA
19.9
Rev Growth YoY
-7.0%
Gross Margin
53.8%
Price Return 3M
2.6%
Price Return 12M
20.7%
Catalyst Signal
+0.15
Market Cap
$15.1B
TTM Revenue
$8.2B
Price / Sales
1.9
ROE
3.2%
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-16 | C- (2.1) | C- (1.9) | B (3.4) | B (3.4) | C (2.4) | C+ (2.6) |
| 2026-11-09 | C- (2.0) | C- (1.9) | B (3.4) | B (3.5) | C (2.4) | C+ (2.6) |
| 2026-11-06 | B- (3.1) | C- (1.9) | B (3.5) | B (3.3) | C (2.2) | C+ (2.8) |
| 2026-11-03 | B- (3.1) | C- (1.9) | B (3.5) | B (3.3) | C- (2.1) | C+ (2.8) |
| 2026-11-02 | B- (3.1) | C- (1.9) | B (3.5) | B- (3.1) | C+ (2.8) | B- (2.9) |
Page
1
of
6